Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2768Carcinoma, Non-Small-Cell Lung 2267Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1050Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 819Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 754Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 685Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 599Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

trastuzumab deruxtecan 2neratinib 1Radiosurgery 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Breast Cancer With Brain Metastasis × Clear all
NCT07152782 2025-09-03

THUNDER

Fudan University

Phase 2 Not yet recruiting
202 enrolled
Breast

Breast Cancer With Brain Metastasis

NCT07150208 2025-09-02

THUMB

Fudan University

Phase 2 Not yet recruiting
140 enrolled
Breast

Breast Cancer With Brain Metastasis

NCT01924351 2020-03-18

HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)

University of Maryland, Baltimore

Phase 2 Withdrawn
Breast

Breast Cancer With Brain Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡